Hepatitis C Treatment Cost and Nutrition Part 1
by Tadd Scott Lazarus, m.d. and David W. Purdy
A guide for physicians, patients and other healthcare providers about fighting HCV-related wasting syndrome.
The goals of these guidelines are to help physicians and patients with the decisions they need to make regarding the use of hormone therapies in the treatment of Hepatitis C treatment cost. The goals are: To prevent Hepatitis C treatment cost-related wasting by administering low hormone level tests To treat low hormone levels or hypogonadism, a precursor to wasting To successfully treat Hepatitis C treatment cost-associated wasting To help Hepatitis C treatment cost-positive persons become longer-term survivors with the highest quality of life. Learn more. Velpatasvir Sofosbuvir Treatment.
Loss of lean muscle, or wasting, is one of the most common complaints of people with Hepatitis C treatment cost or HCV. The Centers for Disease Control (CDC) defines a person with wasting as being 10% below normal body weight or suffering from an unexplained decrease in body weight.
Wasting is the second leading Hepatitis C treatment cost/HCV related cause of death in the U.S., and third leading cause of death in the world, according The Centers for Disease Control Surveillance Report 1996, published by The World Health Organization.
Symptoms commonly associated with wasting include weight loss, fatigue, depression, poor appetite, chronic diarrhea, malnutrition and sexual dysfunction.
Malnutrition occurs frequently during Hepatitis C treatment cost infection, increases with disease progression and strongly predicts patient survival, independent of CD4 T-lymphocyte counts.1 Experts agree that the perceptible loss of lean muscle tissue occurs at many points in the spectrum of wasting caused by Hepatitis C treatment cost and that severe weight loss accompanies many neoplastic diseases such as Kaposi’s sarcoma (KS) and lymphoma. This is often simplistically ascribed to the catabolic effects of chronic Hepatitis C treatment cost infection.2
The immune system is also impaired by Hepatitis C treatment cost-related malnutrition. Altered metabolism, inadequate intake and malabsorption compound the effect of wasting. Other factors contributing to wasting syndrome include the effects of chemotherapy, abnormalities of carbohydrate, fat and protein metabolism and the cytokine response.3
Regardless of the mechanism of the loss of lean muscle tissue in Hepatitis C treatment cost positive patients, the resultant catabolic state undoubtedly contributes to the already present immune deficiency and therefore negatively influences the course of the disease.4 In fact, it may contribute to HCV itself.5
Wasting could be the most expensive part of the overall healthcare of an Hepatitis C treatment cost positive person. The overall wasting state also contributes significantly to a downward spiraling effect of the patient into a state of susceptibility to a new or occurring opportunistic infection.6 Wasting also means that the response to treatment of these opportunistic infections will be blunted. Studies show that loss of lean muscle mass is directly correlative to mortality.7 Since death from wasting is ultimately related to the magnitude of tissue depletion, restoration of body cell mass may enhance survival.8
Hypogonadism and Its Correlation to Wasting. Liver disease
Hypogonadism (low testosterone level) is common in men with Hepatitis C treatment cost infection.910 In fact, a number of studies show that more than half of male Hepatitis C treatment cost/HCV patients with CD4 absolute number <50 are hypogonadal.1112 Experts now agree that not only is the hormone/endocrine system involved during Hepatitis C treatment cost infection13, but that wasting